Medicare Enrolled
Dr. Tejinder Mander, M.D.
Interventional Cardiology · Greenville, MI
Practice pattern: Electrophysiology & Remote
— Practice combining electrophysiology and remote services
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Mander from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mander?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Mander
Dr. Tejinder Mander is an interventional cardiology specialist in Greenville, MI, with 20 years of NPI registration. Based on federal Medicare data, Dr. Mander performed 7,251 Medicare services across 3,011 unique beneficiaries.
Between the years covered by Open Payments, Dr. Mander received a total of $14,938 from 55 pharmaceutical and/or device companies across 767 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in interventional cardiology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Mander is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 7% volume in MI
$14,938 industry payments
Medicare Practice Summary
Medicare Utilization ↗7,251
Medicare services
Top 7% in MI for interventional cardiology
3,011
Unique beneficiaries
$43
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~363 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
1,840 | $0 | $3 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
847 | $86 | $160 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
575 | $10 | $80 |
| Anticoagulant management for warfarin Management of anticoagulant therapy for a patient taking warfarin. This service involves monitoring and adjusting the medication regimen. |
506 | $8 | $40 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
448 | $45 | $75 |
| Remote pacemaker/defibrillator monitoring, 90 days Remote evaluation of a pacemaker or implantable defibrillator system within 90 days of the last check. |
354 | $15 | $73 |
| Remote pacemaker monitoring, 90 days Remote assessment of a pacemaker system, including single, dual, multiple lead, or leadless devices, performed up to 90 days apart. |
327 | $20 | $75 |
| Remote monitoring of implantable heart rhythm device Evaluation of data transmitted remotely from an implantable cardiovascular monitor, such as a loop recorder or subcutaneous cardiac rhythm monitor, over a period up to 30 days. |
277 | $51 | $200 |
| Technetium Tc-99m sestamibi diagnostic injection A diagnostic injection of technetium Tc-99m sestamibi used for imaging studies. |
269 | $105 | $210 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
206 | $137 | $950 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
190 | $59 | $100 |
| Remote monitoring of implantable heart device, up to 30 days Remote evaluation of an implanted heart or blood vessel monitoring system over a period of up to 30 days. |
187 | $17 | $100 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
134 | $47 | $445 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
133 | $319 | $1,000 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
123 | $92 | $160 |
| Pacemaker programming, dual lead system Adjustment and configuration of a dual-lead pacemaker device to ensure proper operation and settings. |
106 | $54 | $115 |
| Remote cardiac rhythm monitor evaluation, up to 30 days Review and analysis of data from a remote cardiac rhythm monitoring system over a period of up to 30 days. |
88 | $19 | $60 |
| Sedation by physician, initial 15 minutes Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older. |
78 | $10 | $60 |
| Heart muscle strain imaging | 58 | $27 | $65 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
58 | $120 | $245 |
| Remote evaluation of implantable defibrillator system Remote assessment of a single, dual, or multiple lead implantable defibrillator system within 90 days of the previous evaluation. |
46 | $28 | $125 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
38 | $137 | $281 |
| 3D radiographic procedure A radiographic imaging technique that creates three-dimensional representations of internal structures. |
35 | $17 | $285 |
| Hospital discharge management, 30+ min This service covers the care provided by a physician or qualified healthcare professional on the day a patient is discharged from the hospital. It requires more than 30 minutes of total time spent on the day of discharge. |
29 | $84 | $200 |
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
27 | $6 | $35 |
| Cardiac catheterization | 26 | $185 | $1,200 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
26 | $135 | $500 |
| Programming of multiple lead implantable defibrillator system Adjustment and testing of the settings for an implanted heart device with multiple leads to ensure proper function. |
25 | $76 | $130 |
| Pacemaker insertion with heart chamber electrodes A surgical procedure to implant a pacemaker device and place electrodes into the upper and lower chambers of the heart to regulate heart rhythm. |
22 | $386 | $1,000 |
| Radiologist review of arm or leg artery image A radiologist reviews images of the arteries in the arm or leg. This process involves analyzing the visual data to assess the blood vessels. |
21 | $65 | $147 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
21 | $58 | $115 |
| Follow-up heart ultrasound An ultrasound of the heart performed to monitor or reassess a previously identified condition or treatment progress. |
20 | $66 | $225 |
| Echocardiogram with color Doppler An ultrasound of the heart that uses color imaging to visualize blood flow, measure flow rate, and assess valve function. |
16 | $15 | $200 |
| Continuous EKG monitoring review, 48-7 days Review and interpretation of continuous external EKG recordings lasting more than 48 hours up to 7 days. |
15 | $18 | $47 |
| Continuous external EKG monitoring, 48 hours to 7 days This procedure involves recording the heart's electrical activity continuously using an external device for a period exceeding 48 hours but not more than 7 days. |
14 | $9 | $35 |
| Continuous external EKG monitoring, 8-15 days This procedure involves recording heart rhythm continuously using an external EKG device over a period of 8 to 15 days. |
14 | $8 | $35 |
| External EKG monitoring, 8-15 days Continuous external electrocardiogram recording and review over a period of 8 to 15 days to monitor heart rhythm. |
14 | $19 | $45 |
| CT scan of heart blood vessels and grafts with contrast A CT scan that uses contrast dye to create detailed images of the heart's blood vessels and any surgical grafts. |
13 | $136 | $1,050 |
| Follow-up ultrasound of heart blood flow, valves and chambers An ultrasound exam that follows up on the heart's blood flow, valves, and chambers. It uses sound waves to create images of the heart's structure and function. |
13 | $16 | $120 |
| Aminophylline injection, up to 250 mg Administration of aminophylline medication via injection for a dose of up to 250 mg. |
12 | $9 | $25 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
15.5% high complexity
40.9% medium
43.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$14,938
Total received (2018-2024)
Avg $2,134/year across 7 years
Top 35% in MI for interventional cardiology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
55
Companies
767
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$14,818 (99.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$120 (0.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,827
2023
$2,075
2022
$2,646
2021
$1,967
2020
$1,652
2019
$2,522
2018
$2,249
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ShockWave Medical, Inc
$414
Novartis Pharmaceuticals Corporation
$218
E.R. Squibb & Sons, L.L.C.
$218
Boehringer Ingelheim Pharmaceuticals, Inc.
$120
Amgen Inc.
$104
Kiniksa Pharmaceuticals International, plc
$93
Merck Sharp & Dohme LLC
$88
Bayer Healthcare Pharmaceuticals Inc.
$85
Novo Nordisk Inc
$77
Vital Connect, Inc
$66
Alnylam Pharmaceuticals Inc.
$55
Janssen Pharmaceuticals, Inc
$39
Esperion Therapeutics, Inc.
$35
Baxter Healthcare
$32
Kestra Medical Technology Services, Inc.
$28
Chiesi USA, Inc.
$27
Actelion Pharmaceuticals US, Inc.
$26
Daiichi Sankyo Inc.
$25
Abbott Laboratories
$24
Impulse Dynamics (USA) Inc.
$21
AstraZeneca Pharmaceuticals LP
$17
PFIZER INC.
$16
Top 3 companies account for 46.5% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Pharmaceuticals, Inc
$1,733
Amgen Inc.
$1,618
AstraZeneca Pharmaceuticals LP
$1,184
Novartis Pharmaceuticals Corporation
$945
E.R. Squibb & Sons, L.L.C.
$826
ShockWave Medical, Inc
$756
Amarin Pharma Inc.
$629
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$614
Boehringer Ingelheim Pharmaceuticals, Inc.
$529
PFIZER INC.
$401
BOSTON SCIENTIFIC CORPORATION
$349
Shockwave Medical, Inc
$340
Merck Sharp & Dohme LLC
$323
Abbott Laboratories
$321
SANOFI-AVENTIS U.S. LLC
$294
Bayer Healthcare Pharmaceuticals Inc.
$293
Bayer HealthCare Pharmaceuticals Inc.
$257
Actelion Pharmaceuticals US, Inc.
$243
Boston Scientific Corporation
$234
Novo Nordisk Inc
$226
Lundbeck LLC
$205
Daiichi Sankyo Inc.
$185
Alnylam Pharmaceuticals Inc.
$183
Kiniksa Pharmaceuticals, Ltd.
$183
Chiesi USA, Inc.
$174
Astellas Pharma US Inc
$148
ARALEZ PHARMACEUTICALS US INC.
$140
Merck Sharp & Dohme Corporation
$140
Medtronic Vascular, Inc.
$136
Regeneron Healthcare Solutions, Inc.
$133
ABIOMED
$126
CSL Behring
$122
Esperion Therapeutics, Inc.
$120
iRhythm Technologies, Inc.
$101
Kiniksa Pharmaceuticals International, plc
$93
Vital Connect, Inc
$66
Bardy Diagnostics, Inc.
$60
Kowa Pharmaceuticals America, Inc.
$54
Terumo Medical Corporation
$49
HOLOGIC INC
$44
Impulse Dynamics (USA) Inc.
$39
AtriCure, Inc.
$39
Janssen Biotech, Inc.
$34
Baxter Healthcare
$32
CHIESI USA, INC.
$31
Lexicon Pharmaceuticals, Inc.
$30
Kestra Medical Technology Services, Inc.
$28
Alexion Pharmaceuticals, Inc.
$23
Aziyo Biologics, Inc.
$20
Amryt Pharma Holdings Ltd
$17
Braemar Manufacturing, LLC
$15
Medtronic USA, Inc.
$14
BSN Medical Inc
$13
Philips Electronics North America Corporation
$13
Aegerion Pharmaceuticals, Inc.
$13
Top 3 companies account for 30.4% of all-time payments
Associated products mentioned in payments ›
(7999) SRC Undivided · 3DQUORUM · ACTIMOVE · ANDEXXA · AQUAMANTYS · Arcalyst · Assure WCD · BRILINTA · CAMZYOS · CARDIOMEMS · CHANTIX · CLEVIPREX · CLEVIPREX 25MG/50ML · CROSSBOSS · Cardiac Monitoring Suite · Carnation Ambulatory Monitor · Confirm Rx · Corlanor · ECM Patch · ELIQUIS · ENTRESTO · EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX · FARXIGA · GENERAL ATHERECTOMY · GENERAL STENTS · GENERAL THERAPIES · General - Therapies · HeartMate 3 Left Ventricular Dev · HeartWare HVAD · Hillrom - Cardiac Ambulatory Monitor · INJECTAFER · Impella · Inpefa · JARDIANCE · JUXTAPID · KENGREAL · Kcentra · Kerendia · LEQVIO · LEXISCAN · LIVALO · LOKELMA · LifeVest · Livalo · MULTAQ · MetaCross · NEXLETOL · NORTHERA · ONPATTRO · OPSUMIT · OPTIMIZER · Optimizer · Ozempic · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Pouch · Repatha · Resolute · Rybelsus · SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER · Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter · UPTRAVI · Ultomiris · VALITUDE · VERQUVO · VITALPATCH RTM · VYNDAQEL · Vascepa · Vascular Lithotripsy · WATCHMAN · WATCHMAN Access System · XARELTO · ZIO Patch · ZIO XT Patch · ZONTIVITY
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Interventional cardiologists within 10 mi
7
Per 100K population
10.4
County median income
$64,892
Nearest hospital
SPECTRUM HEALTH UNITED HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Mander is an electrophysiology & remote specialist, with above-average Medicare volume (top 7% in MI), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Mander experienced with contrast dye for imaging (iodine-based)?
Based on Medicare claims data, Dr. Mander performed 1,840 contrast dye for imaging (iodine-based) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Mander receive payments from pharmaceutical companies?
Yes. Dr. Mander received a total of $14,938 from 55 companies across 767 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mander's costs compare to other interventional cardiologists in Greenville?
Dr. Mander's average Medicare payment per service is $43. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mander) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Interventional Cardiologists in Greenville
Browse interventional cardiologists in Greenville ranked by procedure volume and transparency data.
Highest volume
Top Interventional Cardiologists in MI
Interventional cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Interventional Cardiologists in MI
Which MI interventional cardiologists receive the most from drug and device companies.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology